Correlation Between Pfizer and Simplify Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Simplify Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Simplify Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Simplify Equity PLUS, you can compare the effects of market volatilities on Pfizer and Simplify Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Simplify Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Simplify Equity.

Diversification Opportunities for Pfizer and Simplify Equity

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and Simplify is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Simplify Equity PLUS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Simplify Equity PLUS and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Simplify Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Simplify Equity PLUS has no effect on the direction of Pfizer i.e., Pfizer and Simplify Equity go up and down completely randomly.

Pair Corralation between Pfizer and Simplify Equity

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Simplify Equity. In addition to that, Pfizer is 1.29 times more volatile than Simplify Equity PLUS. It trades about -0.08 of its total potential returns per unit of risk. Simplify Equity PLUS is currently generating about 0.1 per unit of volatility. If you would invest  2,719  in Simplify Equity PLUS on September 3, 2024 and sell it today you would earn a total of  1,797  from holding Simplify Equity PLUS or generate 66.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Simplify Equity PLUS

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Simplify Equity PLUS 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Simplify Equity PLUS are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Simplify Equity may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pfizer and Simplify Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Simplify Equity

The main advantage of trading using opposite Pfizer and Simplify Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Simplify Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Simplify Equity will offset losses from the drop in Simplify Equity's long position.
The idea behind Pfizer Inc and Simplify Equity PLUS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm